Exagen Files First Of Six Planned 510(k)s For Genomic Test Kits
This article was originally published in The Gray Sheet
Executive Summary
Exagen Diagnostics recently filed the first of six planned 510(k) applications for test kits developed using its novel Coperna computational platform, kicking off a major push into the nascent genomic test kit market